- Home
- ANNX vs WOW Comparison
ANNX vs WOW Comparison
Compare ANNX & WOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- WOW
- Stock Information
- Founded
- ANNX 2011
- WOW 2001
- Country
- ANNX United States
- WOW United States
- Employees
- ANNX N/A
- WOW N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- WOW Cable & Other Pay Television Services
- Sector
- ANNX Health Care
- WOW Telecommunications
- Exchange
- ANNX Nasdaq
- WOW Nasdaq
- Market Cap
- ANNX 362.4M
- WOW 356.9M
- IPO Year
- ANNX 2020
- WOW 2017
- Fundamental
- Price
- ANNX $2.81
- WOW $4.80
- Analyst Decision
- ANNX Strong Buy
- WOW Buy
- Analyst Count
- ANNX 7
- WOW 2
- Target Price
- ANNX $15.80
- WOW $7.50
- AVG Volume (30 Days)
- ANNX 1.3M
- WOW 269.8K
- Earning Date
- ANNX 03-25-2025
- WOW 03-12-2025
- Dividend Yield
- ANNX N/A
- WOW N/A
- EPS Growth
- ANNX N/A
- WOW N/A
- EPS
- ANNX N/A
- WOW N/A
- Revenue
- ANNX N/A
- WOW $647,100,000.00
- Revenue This Year
- ANNX N/A
- WOW N/A
- Revenue Next Year
- ANNX N/A
- WOW N/A
- P/E Ratio
- ANNX N/A
- WOW N/A
- Revenue Growth
- ANNX N/A
- WOW N/A
- 52 Week Low
- ANNX $2.64
- WOW $2.31
- 52 Week High
- ANNX $8.40
- WOW $5.80
- Technical
- Relative Strength Index (RSI)
- ANNX 26.19
- WOW 59.73
- Support Level
- ANNX $2.64
- WOW $4.33
- Resistance Level
- ANNX $3.24
- WOW $5.00
- Average True Range (ATR)
- ANNX 0.23
- WOW 0.18
- MACD
- ANNX -0.02
- WOW 0.08
- Stochastic Oscillator
- ANNX 14.77
- WOW 75.88
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About WOW WideOpenWest Inc.
WideOpenWest Inc is a cable operator and broadband service, provider. The company serves residential, business and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Tennessee, Maryland, and South Carolina. Its service portfolio consists of high-speed internet, data, voice, cloud, and cable television services. The company operates in one business segment that is Broadband Services. The majority of the revenue is generated from the subscription service revenue received.